Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-19 3:44 pm Sale | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 0 0% | -1,712,920 (Position Closed) | View |
| 2020-08-12 08:51 am Unchanged | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,712,920 8.8% | 0 (Unchanged) | View |
| 2020-06-24 4:35 pm Purchase | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,712,920 8.8% | 676,880 (+65.33%) | View |
| 2020-04-01 09:33 am Sale | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,036,040 5.4% | -68,893 (-6.24%) | View |
| 2020-02-21 4:05 pm Purchase | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,104,933 5.7% | 74,293 (+7.21%) | View |
| 2020-01-30 09:18 am Unchanged | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,030,640 5.3% | 0 (Unchanged) | View |
| 2019-11-13 10:07 am Purchase | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,030,640 5.3% | 1,030,640 (New Position) | View |